DANAHER CORP /DE/ (DHR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
DANAHER CORP /DE/ (DHR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.2 3 d161342dex102.htm EX-10.2 EX-10.2 Exhibit 10.2 FINAL VERSION AMENDED AND RESTATED DANAHER CORPORATION OMNIBUS INCENTIVE PLAN LONG-TERM GROWTH AWARD OPTION AGREEMENT Unless otherwise defined herein, the terms defined in the Amended and Restated Danaher Corporation Omnibu
How this was made
The 30-second read
Why it matters
Equity-compensation agreements can affect expectations for dilution and executive alignment, but the excerpt is primarily legal/administrative language about option vesting and exercise mechanics.
Market read
A routine governance and equity-compensation disclosure with no valuation-driving numbers in the provided text.
What to watch
If the full 8-K includes specific officer/director appointments or option grant quantities, that could change relevance. The provided excerpt does not show those specifics.
Background
The filing is an SEC Form 8-K Item 5.02 covering director/officer changes and compensatory arrangements, with an exhibit describing a long-term growth award option agreement under Danaher’s omnibus incentive plan.
Ticker impact
Danaher (DHR) filed an 8-K Item 5.02 describing compensatory arrangements tied to a long-term growth award option agreement under its incentive plan.
Low likelihood of a sustained price move from this specific excerpt alone; any reaction would be limited and event-driven around equity-compensation details not shown here.
The excerpt is an SEC 8-K with an exhibit describing option grant mechanics (vesting, exercise, auto-exercise) but does not include grant size, recipients, or financial terms that would materially change valuation.
Market effects
Minimal. Equity-compensation plan mechanics are common across industrial/healthcare tools and do not signal sector-level change by themselves.
None indicated.
None indicated.
Counterpoint
Traders may overreact to any equity-compensation filing; without grant size or performance conditions, the market impact is likely negligible.
Key entities
- issuerDanaher Corporation
Subject of the SEC 8-K Item 5.02 and the equity option agreement exhibit.
- equity_planDanaher Corporation Omnibus Incentive Plan
The plan under which the long-term growth award option agreement is governed.
